The World's Greatest Investing Community
Results 121 - 130 of 213 : Previous 9 10 11 12 13 14 15 16 17 Next
Every Investor Should Know This Stock Tool
Use DuPont analysis to breakdown the profitability of stocks.
Should You Let AstraZeneca Go?
Multiple drug patent expirations await. It's time to run away.
Clinical Trial Positive! Shares Just Barely
A story about expectations.
3 high-turnover funds that might be good to own in a tax-deferred account like a 401k.
Tablets and takeovers took bows this past week.
Avoid This Multibillion-Dollar Market
It's just too crowded.
It's Up! It's Down! It's Dendreon!
The joys of biotech.
Now That's What I Call a Drug That Works
Seattle Genetics hits a home run -- and then some.
Prepare for This $12 Billion Whoosh
Lipitor going generic leaves a hole, but be careful filling it.
These Companies Smile at Avandia's Woes
Losers and winners are like yin and yang.
Results 121 - 130 of 213 : Previous 9 10 11 12 13 14 15 16 17 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK